At the request of Scandion Oncology, Scandion Oncology equity rights will be
traded on First North Growth Market as from July 19, 2024.
Security name: Scandion Oncology TO 3
--------------------------------------
Short name: SCOL TO 3
--------------------------------------
ISIN code: DK0062957114
--------------------------------------
Orderbook ID: 345978
--------------------------------------
Terms: One (1) warrant series TO 3 entitles the holder to subscribe for one (1)
new share in the Company to a subscription price corresponding to
seventy (70) per cent of the volume weighted average price of the
Company's share during the period from and including 14 March 2025 up
to and including 27 March 2025, however not lower than the shares'
nominal value and not higher than 150 per cent of the subscription
price in the Rights Issue. Subscription of shares by exercise of
warrants of series TO 3 will take place during the period from and
including 2 April 2025 up to and including 16 April 2025.
--------------------------------------------------------------------------------
1 option rights gives the right to subscribe for 1 new share in Scandion
Oncology
--------------------------------------------------------------------------------
Subscr April 2, 2025 - April 16, 2025
iption
perio
d:
--------------------------------------------------------------------------------
Last April 14, 2025
tradi
ng
day:
--------------------------------------------------------------------------------
This information is distributed at the request of the Certified Adviser, Västra
Hamnen Corporate Finance AB. For further information, please call Västra Hamnen
Corporate Finance AB on 040 200 250.© 2024 GlobeNewswire
